<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>15462</id><no>AL002-LTE</no><status>Open (affiliates only)</status><title>A MULTICENTER, LONG-TERM EXTENSION STUDY TO EVALUATE&#xD;
THE SAFETY, TOLERABILITY, AND EFFICACY OF AL002 IN&#xD;
PARTICIPANTS WITH ALZHEIMER&amp;#8217;S DISEASE</title><nct_id>NCT05744401</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><disease_site>Other</disease_site><PI>Turner, Raymond</PI><institution>Georgetown University Medical Center; Lombardi Comprehensive Cancer Center</institution><management_group>GUMC Neurology</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>